İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023 · article

Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study

ISSN0342-4642
YÖKSİS OpenAlex Açık erişim · hybrid Üst %1
Yıl2023
Atıf165OpenAlex
Atıf145Semantic Scholar · 15 etkili
Yüzdelik%99,8
FWCI23,991,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıIntensive care medicine
  • Katalog eşleşmesi (ISSN)Intensive Care Medicine
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

PURPOSE: The incidence, patient features, risk factors and outcomes of surgery-associated postoperative acute kidney injury (PO-AKI) across different countries and health care systems is unclear. METHODS: We conducted an international prospective, observational, multi-center study in 30 countries in patients undergoing major surgery (> 2-h duration and postoperative intensive care unit (ICU) or high dependency unit admission). The primary endpoint was the occurrence of PO-AKI within 72 h of surgery defined by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Secondary endpoints included PO-AKI severity and duration, use of renal replacement therapy (RRT), mortality, and ICU and hospital length of stay. RESULTS: We studied 10,568 patients and 1945 (18.4%) developed PO-AKI (1236 (63.5%) KDIGO stage 1500 (25.7%) KDIGO stage 2209 (10.7%) KDIGO stage 3). In 33.8% PO-AKI was persistent, and 170/1945 (8.7%) of patients with PO-AKI received RRT in the ICU. Patients with PO-AKI had greater ICU (6.3% vs. 0.7%) and hospital (8.6% vs. 1.4%) mortality, and longer ICU (median 2 (Q1-Q3, 1-3) days vs. 3 (Q1-Q3, 1-6) days) and hospital length of stay (median 14 (Q1-Q3, 9-24) days vs. 10 (Q1-Q3, 7-17) days). Risk factors for PO-AKI included older age, comorbidities (hypertension, diabetes, chronic kidney disease), type, duration and urgency of surgery as well as intraoperative vasopressors, and aminoglycosides administration. CONCLUSION: In a comprehensive multinational study, approximately one in five patients develop PO-AKI after major surgery. Increasing severity of PO-AKI is associated with a progressive increase in adverse outcomes. Our findings indicate that PO-AKI represents a significant burden for health care worldwide.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

165atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 32 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  2. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  3. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial.Atıf 29 · OpenAlex
  4. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  5. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  6. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  7. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  8. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  9. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS‑AKI trialAtıf 29 · OpenAlex
  10. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex

Yazarlar

79
  1. Raphae Weiss 1
  2. Alexander Zarbock 2
  3. Felix Albert 3
  4. Kristen Rutledge 4
  5. John A Kellum 5
  6. Rinaldo Bellomo 6
  7. Evgeny Grigoryev 7
  8. Angel M Candela-Toha 8
  9. Vincent Legros 9
  10. ZELİHA ASLI DEMİR 10
  11. Peter Rosenberger 11
  12. Patricia Galan Mendez 12
  13. Ke Peng 13
  14. Maxime Leger 14
  15. Wegdan Khalel 15
  16. Melanie Meersch 16
  17. MUKADDER ORHAN SUNGUR 17
  18. ÖZLEM KORKMAZ DİLMEN 18
  19. FATMA AKCİL EREN 19
  20. YUSUF TUNALI 20
  21. GÜLAY OK 21
  22. EDA TOK ALSİNA 22
  23. POLAT CENGİZ BEKTAŞ 23
  24. NURCAN KIZILCIK 24
  25. ÖZNUR ŞEN 25
  26. KAMİL DARÇIN KOÇ ÜNİVERSİTESİ 26
  27. SEMRA UĞUR 27
  28. YAVUZ GÜRKAN 28
  29. KEMAL TOLGA SARAÇOĞLU 29
  30. ÖZGE YILDIZ KOYUNCU 30
  31. NADİDE AYSUN POSTACI 31
  32. AYŞEGÜL ÖZGÖK 32
  33. ÜMİT KARADENİZ 33
  34. HÜLYA YİĞİT ÖZAY 34
  35. EDA BALCI 35
  36. NEVRİYE SALMAN 36
  37. BEHİÇ GİRGİN 37
  38. ÖZLEM SAĞIR 38
  39. HAFİZE FİSUN DEMİR 39
  40. HÜSEYİN İLKSEN TOPRAK 40
  41. MUSTAFA SONER ÖZCAN 41
  42. FİLİZ ALKAYA SOLMAZ 42
  43. MEHMET YILMAZ 43
  44. ÜMRAN KARACA 44
  45. SEVTAP HEKİMOĞLU ŞAHİN 45
  46. SÜHEYLA KARADAĞ ERKOÇ 46
  47. NESLİHAN ALKIŞ ANKARA ÜNİVERSİTESİ 47
  48. VOLKAN BAYTAŞ ANKARA ÜNİVERSİTESİ 48
  49. ENGİN ERTÜRK 49
  50. SEDAT SAYLAN 50
  51. ALİ AKDOĞAN 51
  52. BEYZA BÜYÜKGEBİZ YEŞİL 52
  53. ÖMER FARUK BORAN 53
  54. YAVUZ ORAK KAHRAMANMARAŞ SÜTÇÜ İMAM ÜNİVERSİTESİ 54
  55. FEYZA ÇALIŞIR 55
  56. SİBEL BÜYÜKÇOBAN 56
  57. BAHAR KUVAKİ BALKAN 57
  58. SEDA CANSABUNCU 58
  59. SELCAN AKESEN 59
  60. SUNA GÖREN 60
  61. TUĞÇE YENİOCAK 61
  62. OSMAN ORMAN 62
  63. ÖZLEM ERSOY KORKA 63
  64. TÜLAY ŞAHİN 64
  65. NERMİN A. OSMAN 65
  66. DEMET ALTUN BİNGÖL 66
  67. NUR CANBOLAT 67
  68. SERAP AKTAŞ YILDIRIM ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ 68
  69. MÜŞERREF BERİL DİNÇER MUTLU 69
  70. MÜZEYYEN İYİGÜN 70
  71. DAVUD YAPICI 71
  72. ASLINUR SAGÜN 72
  73. LEVENT ÖZDEMİR 73
  74. NEVAL BOZTUĞ 74
  75. EMEL GÜNDÜZ AKDENİZ ÜNİVERSİTESİ 75
  76. DEMET LAFLI TUNAY 76
  77. DENİZ KARAKAYA 77
  78. BURHAN DOST 78
  79. ÖZGÜR KÖMÜRCÜ 79